$SRE

Goldman Sachs Adjusts Price Target on Sempra to $110 From $109, Maintains Buy Rating

Goldman Sachs raised its price target on Sempra to $110 from $109 and kept a Buy rating, according to the note cited in the article. The update matters for traders tracking analyst revisions and sentiment around Sempra shares.

Original reporting
Published Aug 10, 2026, 11:33 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 8:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$SRE
Bullish
medium confidence
Mentioned
$SRE
Relevance
4/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$SREBullishLow
01

Why it matters

The disclosed impact is primarily sentiment and positioning, not a fundamental re-rating backed by new operational data in the provided text.

02

Market read

Traders may see incremental bullish sentiment from the PT increase, but the text lacks new earnings, guidance, or regulatory catalysts.

03

What to watch

Without the underlying valuation drivers or updated assumptions, traders should treat this as sentiment noise unless corroborated by earnings/guidance or revised estimates elsewhere.

Relevance 4/10Novelty 4/10Timing: pre-market today (PT change reported at 07:33 am EDT)

Background

The article is a brokerage note summary stating Goldman Sachs adjusted Sempra’s price target while maintaining its Buy rating.

Company-level read

Ticker impact

$SREBullishMedium confidence
Context

Goldman Sachs raised Sempra’s price target to $110 from $109 and kept a Buy rating, signaling updated valuation expectations.

Expected impact

Mild positive bias for SRE, with limited follow-through unless other catalysts (earnings, guidance, regulatory updates) emerge.

Evidence & confidence

The only disclosed new fact is the analyst price target revision; there are no earnings numbers, guidance changes, or operational/regulatory developments in the text.

Market effects

Limited sector read-through because the article contains only an analyst PT update for a single utility/energy infrastructure name.

No specific regional catalyst beyond general US analyst sentiment.

No global macro or cross-border transaction details provided.

Counterpoint

A one-dollar PT tweak with no new fundamentals may not justify chasing the stock; price action may already reflect prior analyst expectations.

Key entities

  • Sempra

    Subject of the analyst price target adjustment and maintained Buy rating.

  • Goldman Sachs

    Brokerage issuing the price target change to $110 from $109.

Related articles

$SREMed

Sempra Energy Q2 Earnings Call Highlights

Sempra Energy (SRE) said it expects Texas to exceed 60% of its total rate base by 2030, driven by Oncor. Oncor’s five-year base capital plan totals $47.5B plus $10B incremental opportunities through 2030, tied to ERCOT’s Batch Zero. Sempra also discussed Ecogas sale approval, ECA LNG Phase 1 damage, and leadership changes tied to the SI Partners transaction.

$SREMedAI 8/10

Sempra’s Q2 Earnings Beat Street. The Revenue Miss Didn’t Matter.

Sempra (SRE) reported Q2 2026 adjusted EPS of $1.16, above the $1.06 Street estimate, while revenue fell to $2.997B versus $3.12B expected. Management kept 2026 adjusted EPS guidance at $4.80 to $5.30 and 2027 at $5.10 to $5.70. The article highlights Texas earnings growth and Oncor’s Batch Zero pipeline.

$SREMed

Sempra Q2 GAAP earnings rise to $796 million

Sempra (SRE) reported Q2 2026 GAAP earnings attributable to common shares of $796 million, or $1.21 per diluted share, up from $461 million, or $0.71, a year earlier. Revenues were $2.997 billion. It raised full-year 2026 GAAP EPS guidance to $5.02-$5.55 and affirmed adjusted EPS of $4.80-$5.30. Capex was $2.226 billion; a 45% sale to KKR affiliates is expected to close in Q3 2026.

$SREMedAI 8/10

Sempra's Q2 Earnings Outpace Estimates, Revenues Fall Y/Y

Sempra (SRE) reported Q2 2026 adjusted EPS of $1.16, above the Zacks Consensus of $1.01, while revenues were $2.997B, below the $3.22B estimate. GAAP EPS was $1.21. Segment earnings rose in California, Texas Utilities, and Infrastructure. Sempra guided 2026 adjusted EPS to $4.80-$5.30 and 2027 EPS to $5.10-$5.70.